US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

DRRX

Durect (DRRX)

Durect Corp

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DRRX

1 2 3 4 5 6 7 8 9 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
07/05/2024	15:30	PR Newswire (US)	DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update	NASDAQ:DRRX	Durect Corp
30/04/2024	06:00	PR Newswire (US)	DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis	NASDAQ:DRRX	Durect Corp
27/03/2024	15:01	PR Newswire (US)	DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:DRRX	Durect Corp
20/03/2024	15:30	PR Newswire (US)	DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update	NASDAQ:DRRX	Durect Corp
04/03/2024	10:37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DRRX	Durect Corp
04/03/2024	06:00	PR Newswire (US)	DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada	NASDAQ:DRRX	Durect Corp
14/02/2024	15:16	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:DRRX	Durect Corp
07/02/2024	17:48	PR Newswire (US)	DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:DRRX	Durect Corp
13/11/2023	15:05	PR Newswire (US)	DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update	NASDAQ:DRRX	Durect Corp
09/11/2023	15:30	PR Newswire (US)	DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update	NASDAQ:DRRX	Durect Corp
07/11/2023	15:01	PR Newswire (US)	DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on Mortality	NASDAQ:DRRX	Durect Corp
07/09/2023	06:00	PR Newswire (US)	DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis	NASDAQ:DRRX	Durect Corp
31/08/2023	15:30	PR Newswire (US)	DURECT Corporation Announces Presentations in Upcoming Investor Conferences	NASDAQ:DRRX	Durect Corp
10/08/2023	15:21	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:DRRX	Durect Corp
10/08/2023	15:18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DRRX	Durect Corp
09/08/2023	15:05	PR Newswire (US)	DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update	NASDAQ:DRRX	Durect Corp
03/08/2023	15:30	PR Newswire (US)	DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business Update	NASDAQ:DRRX	Durect Corp
21/07/2023	09:38	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:DRRX	Durect Corp
20/07/2023	07:00	PR Newswire (US)	DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	NASDAQ:DRRX	Durect Corp
23/06/2023	16:34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRRX	Durect Corp
22/06/2023	15:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DRRX	Durect Corp
07/06/2023	05:00	PR Newswire (US)	DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis	NASDAQ:DRRX	Durect Corp
08/05/2023	15:05	PR Newswire (US)	DURECT Corporation Reports First Quarter 2023 Financial Results and Business Update	NASDAQ:DRRX	Durect Corp
01/05/2023	18:03	PR Newswire (US)	DURECT Corporation to Announce First Quarter 2023 Financial Results and Provide Business Update on May 8	NASDAQ:DRRX	Durect Corp
27/04/2023	16:11	PR Newswire (US)	DURECT Corporation to Host KOL Event on Alcohol-Associated Hepatitis	NASDAQ:DRRX	Durect Corp
27/04/2023	15:52	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:DRRX	Durect Corp
27/04/2023	15:43	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:DRRX	Durect Corp
27/04/2023	15:33	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:DRRX	Durect Corp
25/04/2023	17:45	PR Newswire (US)	DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference	NASDAQ:DRRX	Durect Corp
10/04/2023	05:00	PR Newswire (US)	DURECT Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2a Study of Larsucosterol in Alcohol-Associated Hepatitis	NASDAQ:DRRX	Durect Corp

Showing the most relevant articles for your search:NASDAQ:DRRX

1 2 3 4 5 6 7 8 9 Próxima >

Gold vs US Dollar

US Dollar vs MXN

Bank of America

JP Morgan Chase

Euro vs US Dollar

Invesco QQQ Trust Series 1

Verizon Communications

Health Care Select Sector

American Express

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones